G. Meletis
Molecular Medicine · 2016
A researcher in the Science corpus: 1 paper; trusts 6 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Medicine — 10 citations into it; #123 of 296 by trust here, #288 by citations
- Endocrinology — 5 citations into it; #85 of 250 by trust here, #241 by citations
Whom G. Meletis trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Meletis overall
Papers from G. Meletis's perspective
Ordered by how strongly the researchers G. Meletis trusts endorse each paper. Same corpus, a different order for every researcher.
- Metallo-β-Lactamases: the Quiet before the Storm? (Clinical Microbiology Reviews)
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. (Lancet. Infectious Diseases (Print))
- Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India (Antimicrobial Agents and Chemotherapy)
- OXA-48-like carbapenemases: the phantom menace. (Journal of Antimicrobial Chemotherapy)
- The emerging NDM carbapenemases. (Trends in Microbiology)
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
- Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. (Clinical Infectious Diseases)
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions (Clinical Microbiology Reviews)
- Clinical development success rates for investigational drugs (Nature Biotechnology)
Their papers
- Carbapenem resistance: overview of the problem and future perspectives (2016) — 666 citations